Back to News
Market Impact: 0.5

Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

REGNALNY
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsHealthcare & Biotech
Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Regeneron (REGN) is anticipated to report a year-over-year decline in Q2 2025 earnings and revenue, with consensus estimates at $8.15 EPS (down 29.5%) and $3.34 billion revenue (down 5.7%). Despite a 6.49% downward revision in the consensus EPS estimate over the past 30 days, the company is projected to beat these expectations. This forecast is driven by a +7.62% Zacks Earnings ESP, indicating a Most Accurate Estimate higher than consensus, combined with a Zacks Rank of #3 (Hold), which historically suggests a strong likelihood of an earnings beat for its August 1 release.

Analysis

Regeneron is approaching its Q2 2025 earnings announcement with a complex outlook, characterized by low consensus expectations but a high probability of an earnings surprise. The market consensus anticipates a significant year-over-year contraction, with revenues projected to fall 5.7% to $3.34 billion and earnings per share (EPS) to decline 29.5% to $8.15. This bearish baseline is reinforced by a 6.49% downward revision in the consensus EPS estimate over the last 30 days. However, a key counter-signal is the company's positive Zacks Earnings ESP of +7.62%, which indicates that the most recent analyst revisions are more optimistic than the consensus. This metric, combined with a Zacks Rank of #3 (Hold), creates a scenario that has historically led to a positive earnings surprise nearly 70% of the time. While Regeneron beat estimates in three of the last four quarters, it did miss in the most recent period, introducing a degree of uncertainty. The central dynamic for investors is not the absolute performance but the result relative to these lowered expectations; the subsequent stock reaction will likely be contingent on management's forward guidance during the earnings call.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo